Anteo Diagnostics to Acquire Established Global Diagnostics Company DIAsource ImmunoAssays SA

26 August 2015 – The Board of Directors of Anteo Diagnostics (ASX: ADO) (Anteo) is pleased to announce that it will acquire DIAsource ImmunoAssays, SA (DIAsource), an established global specialty

Continue
CEO Activities Report – Quarter Ended 30 June 2015

The Company has been extremely busy in the period since our last report. This CEO Activities Report provides context and further information on the highlights of last quarter. In summary:

Continue
Gearing Up For AACC: Anteo Extends Relationship with Sigma-Aldrich

Leading up to AACC, Anteo announced the distribution of their Mix&Go™ product range through Sigma-Aldrich. Mix&Go Reagents, Coupling and Activation Kits are expected to be available during Q3 of CY2015.

Continue
SCIENION and Anteo Partner to Develop Consumables for Better Functionality and Longer Shelf Life of Protein Microarrays

SCIENION, a leading global provider of ultra-low volume precision liquid handling systems, and Australian biotech company Anteo Technologies today announced that they have partnered to co-develop protein microarray consumables using

Continue
Van Leeuwenhoeck Research: Anteo Diagnostics – Emerging Leader in Nanotechnology

On July 13 2015, Van Leeuwenhoeck released their Research Note about Anteo Diagnostics. The highlights include: In the IVD market, Anteo is successfully implementing a strategy that has the ability

Continue